Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-01

FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alfuzosin Hydrochloride from Sun Pharmaceutical Industries, Inc., updating the product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride)

Snippet

SUPPL AP for ALFUZOSIN HYDROCHLORIDE (ALFUZOSIN HYDROCHLORIDE)